Risk assessment of hepatitis C virus seroconversion in haemodialysis patients and units at Sohag

Marcel W. Keddeas; Ossama A. Ahmed; Hisham Samy; AbdElaziz Mahmoud; Maha A. El-Tony

doi:10.1097/01.elx.0000440961.86687.60

Citations

388

Views

Abstract not available for this publication.

Cite this Article (APA)

Marcel, W. K., Ossama, A. A., Hisham, S., AbdElaziz, M., Maha, A. E. (2014). Risk assessment of hepatitis C virus seroconversion in haemodialysis patients and units at Sohag. Egyptian Liver Journal. https://doi.org/10.1097/01.elx.0000440961.86687.60

Gamal Shiha; Seham Seif; Maha Maher; Shahera Etreby; Waleed Samir; Khaled Zalata · 2014

cites

389

Tissue microarray as a research tool to study non-neoplastic liver diseases

Mohamed H. Abdel-Rahman; Ahmad A. Agour; Dina S. El-Azab · 2014

cites

388

Prevalence of hepatitis C virus seroconversion among hemodialysis patients in Egypt

Iman I. Sarhan; Cherry R. Kamel · 2015

cites

391

Prevention of paracentesis-induced circulatory dysfunction